Changes in fibrinolysis and severity of organ failure in sepsis: A prospective observational study using point-of-care test-ROTEM

Journal of Critical Care

Volumn 30, Issue 2, 2015, Pages 264-270

  Prakash, Shivesh ^a   Verghese, Santosh ^a   Roxby, David ^a   Dixon, Dani ^a   Bihari, Shailesh ^a   Bersten, Andrew ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Coagulation; Fibrinolysis; Plasminogen activator inhibitor 1; ROTEM; Sepsis; Thromboelastometry

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; PROTHROMBIN FRAGMENT; UNCLASSIFIED DRUG; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PEPTIDE FRAGMENT; PROTHROMBIN FRAGMENT 1.2;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POINT OF CARE TESTING; PROSPECTIVE STUDY; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; THROMBIN TIME; THROMBOELASTOGRAPH; BLOOD; BLOOD CLOTTING; GERMANY; HOSPITAL INFORMATION SYSTEM; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; THROMBOELASTOGRAPHY;

ADULT; AGED; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; GERMANY; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; PROTHROMBIN; SEPSIS; THROMBELASTOGRAPHY;

EID: 84923005443     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.10.014     Document Type: Article

References (28)

1. Vincent J.L., Nelson D.R., Williams M.D. Is worsening multiple organ failure the cause of death in patients with severe sepsis?. Crit Care Med 2011, 39:1050-1055.
2. Hermans P.W., Hibberd M.L., Booy R., Daramola O., Hazelzet J.A., de Groot R., et al. 4G-5G promoter polymorphism in the plasminogen-activatorinhibitor-1 gene and outcome of meningococcal disease. Lancet 1999, 354:556-560.
3. Yamamoto K., Loskutoff D.J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996, 97:2440-2451.
4. Biemond B.J., Levi M., Ten Cate H., Van der Poll T., Büller H.R., Hack C.E., et al. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci (Lond) 1995, 88:587-594.
5. Westendorp R.G., Hottenga J.J., Slagboom P.E. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999, 354:561-563.
6. Sawdey M.S., Loskutoff D.J. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor alpha, and transforming growth factor-beta. J Clin Invest 1991, 88:1346-1353.
7. Levi M., van der Poll T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-S34.
8. Sivula M., Pettilä V., Niemi T.T., Varpula M., Kuitunen A.H. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009, 20:419-426.
9. Velik-Salchner C., Streif W., Innerhofer P., Maier S., Knotzer H., Pajk W., et al. Endotoxinemia-induced changes in coagulation as measured by rotation thrombelastometry technique and conventional laboratory tests: results of a pilot study on pigs. Blood Coagul Fibrinolysis 2009, 20:41-46.
10. Miller B.E., Guzzetta N.A., Tosone S.R., Levy J.H. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000, 90:1324-1330.
11. Spiel A.O., Mayr F.B., Firbas C., Quehenberger P., Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006, 4:411-416.
12. Luddington R.J. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005, 27:81-90.
13. Schöchl H., Frietsche T., Pavelka M., Jámbor C. Hyperfibrinolysis following major trauma: differential diagnosis of lysis patterns and prognostic value of thromboelastometry. J Trauma 2009, 67:125-131.
14. ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
15. Ferreira F.L., Bota D.P., Bross A., Mélot C., Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758.
16. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22:707-710.
17. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. APIC Infection Control and Applied Epidemiology: Principles and Practice 1996, A1-A20. Mosby, St. Louis. R. Olmsted (Ed.).
18. Binder B.R., Christ G., Gruber F., Grubic N., Hufnagl P., Krebs M., et al. Plasminogen activator inhibitor 1: physiological and pathophysiological Roles. News Physiol Sci 2002, 17:56-61.
19. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010, 38:S35-S42.
20. Levi M. Keep in contact: the role of the contact system in infection and sepsis. Crit Care Med 2000, 28:3765-3766.
21. Adamzik M., Eggmann M., Frey U.H., Görlinger K., Bröcker-Preuss M., Marggraf G., et al. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010, 14:R178.
22. Dhainaut J.F., Shorr A.F., Macias W.L., Kollef M.J., Levi M., Reinhart K., et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005, 33:341-348.
23. Zacharowski K., Sucker C., Zacharowski P., Hartmann M. Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006, 95:557-561.
24. Nar H., Bauer M., Stassen J.M., Lang D., Gils A., Declerck P.J. Plasminogen activator inhibitor-1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. J Mol Biol 2000, 297:683-695.
25. Faust S.N., Levin M., Harrison O.B., Goldin R.D., Lockhart M.S., Kondaveeti S., et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345:408-416.
26. Greene R., Lind S., Jantsch H., Wilson R., Lynch K., Jones R., et al. Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy. Am J Roentgenol 1987, 148:501-508.
27. Vasquez Y., Williams C.H., Hardaway R.M. Effect of urokinase on disseminated intravascular coagulation. J Appl Physiol 1998, 85:1421-1428.
28. Ambrus J.L., Ambrus C.M. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals. J Med 1990, 21:67-84.